Salute e Benessere
South Texas Blood and Tissue Center First US Civilian Blood Center to Install Velico's FrontlineODP™ System
The produces "on demand" spray dried plasma, a revolutionary solution for transfusion in environments where conventional plasma products (often frozen) are unavailable or logistically challenging to use. Velico's proprietary spray drying manufacturing process creates a powdered plasma product that is stable at ambient temperature, can be reconstituted with sterile water and is ready for transfusion in approximately . This technology is anticipated to transform plasma transfusion accessibility for:
Richard Meehan , President and CEO of Velico Medical, expressed excitement about the collaboration with STBT on the Blood Center Education Program. He emphasized that the partnership aims to generate valuable insights for advancing best practices in service, supporting the future commercial launch of the FrontlineODP™ spray dried plasma system, and equipping customers for manufacturing readiness. "FrontlineODP™ has the potential to be a transformative, life-saving solution for emergency medical providers, with the capability to save thousands of lives annually," Meehan stated.
"Participating in the BCEP program provides us the opportunity to continue our history of firsts in serving bleeding patients and those who treat them in our region and across the country," says Audra Taylor, Executive Director of Blood Operations and former Division Chief of the Armed Services Blood Program (ASBP) for the Defense Health Agency. She adds, "I fully expect that FrontlineODP will enable us to provide life-saving plasma to many EMS and emergency medical providers currently unable to carry conventional liquid blood products due to logistical challenges and product availability."
Investigational device. Limited by Federal (or US) law to investigational use.
The FrontlineODP™ System is currently under investigation and has not received FDA approval for any indication.
Velico's development program has been funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50121C00059.
Velico, Inc. is a private US medical technology company, committed to the mission of eliminating preventable death from bleeding. Headquartered in
Beverly, Massachusetts , USA. Velico personnel have substantial expertise and experience in transfusion medicine and medical device development. In support of its mission, Velico is developing partnerships with civilian, government and military blood center leadership, trauma surgeons, emergency medical physicians, military medics and first responders worldwide.
For more information visit veli.co
South Texas Blood & Tissue supplies blood components to more than 100 hospitals in
South Texas and supports tissue, research/new therapies, and umbilical cord blood/birth tissue donations.
The BioBridge Global family of nonprofits includes South Texas Blood & Tissue, QualTex Laboratories, GenCure and The Blood & Tissue Center Foundation. For 50 years, we have worked with the healthcare community to provide lifesaving therapies to patients and to support advances in advanced therapies.
For more information visit ImpactLife.org
Logo - https://mma.prnewswire.com/media/2609928/Velico_Medical_Logo_Logo.jpg
Photo - https://mma.prnewswire.com/media/2609929/Bill_Skillman.jpg
Photo - https://mma.prnewswire.com/media/2609930/Velico_Medical.jpg
View original content:https://www.prnewswire.co.uk/news-releases/south-texas-blood-and-tissue-center-first-us-civilian-blood-center-to-install-velicos-frontlineodp-system-302364781.html